Medical Condition News

RSS

Array BioPharma to present positive interim results of Phase 1 ARRY-380 trial at ASCO Symposium

Array BioPharma Inc. today announced positive interim results of its novel, oral HER2 (ErbB2) inhibitor, ARRY-380, in a Phase 1 trial in patients with advanced cancer.

4 Oct 2010

Socioeconomic status impacts colorectal cancer incidence

People living in economically deprived neighborhoods were more likely to be diagnosed with late-stage, non-localized colorectal cancer, even after researchers controlled for known colorectal cancer risk factors, according to data presented at the Third American Association for Cancer Research Conference on The Science of Cancer Health Disparities, being held Sept. 30-Oct. 3, 2010.

4 Oct 2010

CEUS ultrasound offers superior efficacy to CT scans

Contrast-enhanced ultrasound (CEUS) can be used to evaluate and monitor inflammatory bowel disease (IBD) without exposing patients to CT scans or ionizing radiation, according to a report announced today (Friday) at the ICUS Bubble Conference in Chicago.

4 Oct 2010

BMC researchers receive grants to study effectiveness of integrative medicine in underserved patients

Two Boston Medical Center (BMC) researchers have each been awarded grants from the NIH National Center for Complementary and Alternative Medicine (NCCAM) to study the effectiveness of integrative medicine in underserved patients.

4 Oct 2010

Scientists find several common findings on diabetes management

Diabetes is on the rise. The seventh leading cause of death in the U.S. today, it affects 24 million people, nearly 3 times the number in 1980. Another 57 million have a condition that puts them at heightened risk of the illness.

3 Oct 2010

Vitamin D deficiency in African-American women can increase risk of aggressive breast cancer: Study

African-American women had lower vitamin D levels than white women, and vitamin D deficiency was associated with a greater likelihood for aggressive breast cancer, according to data presented at the Third AACR Conference on the Science of Cancer Health Disparities.

3 Oct 2010

Study shows low DRC level may increase risk for non-melanoma skin cancer

DNA repair capacity (DRC) measurements effectively identified individuals who were at high risk for non-melanoma skin cancer, and may be a useful method to evaluate the efficacy of preventive therapies, according to study results presented at the Third AACR Conference on the Science of Cancer Health Disparities.

3 Oct 2010

Celsion presents Phase I/II DIGNITY trial data at 2010 Breast Cancer Symposium

Celsion Corporation announced today that interim data from its Phase I/II DIGNITY trial of ThermoDox in Recurrent Chest Wall (RCW) Breast Cancer were presented at the poster session at the 2010 Breast Cancer Symposium.

3 Oct 2010

Sulindac drug derivative effective in preventing colon cancer: Research

Researchers in the Division of Cancer Prevention, Department of Medicine, at Stony Brook University have discovered that a novel derivative of sulindac, a non-steroidal anti-inflammatory drug (NSAID) known to prevent colon cancer, is more effective and safer than sulindac in preventing colon cancer in animals. The study results are reported in the October issue of the journal Gastroenterology.

3 Oct 2010

Isotechnika announces CONFIRM1 clinical trial results at TCT 2010 Symposium

Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical trial conducted by its medical device partner, Atrium Medical Corporation, were presented by Glenn Van Langenhove, MD, PhD (Middelheim Hospital in Antwerp, Belgium), the principal investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Scientific Symposium in Washington, DC last week.

3 Oct 2010

Osteoporosis common but underestimated in old men: Study

According to the latest research osteoporosis a diseases common in women that makes bones brittle and easily breakable with age also affects men. The study suggests that this debilitating condition is often overlooked in elderly Australian men.

3 Oct 2010

Shoulder pain costs American health system $7 billion

25 out of 1,000 visits to the family doctor are related to shoulder pain. This is currently the cause of 13% of sick leaves, and it costs the American health system 7 billion dollars.

1 Oct 2010

Argos' AGS-003 in combination with sunitinib demonstrates favorable PFS for renal cell carcinoma

Argos Therapeutics announced that its Arcelis immunotherapy for renal cell carcinoma (RCC), AGS-003, demonstrated favorable progression-free survival (PFS) and safety in combination with sunitinib, based upon updated results from an ongoing Phase 2 trial.

1 Oct 2010

Activating rearrangements in receptor genes are more common than previously thought

A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,--an MSKCC surgeon, researcher and the Director of the Brain Tumor Center--and was published in the October 1 issue of the journal Genes & Development.

1 Oct 2010

Vibrant joins Bike MS NYC to raise money for National Multiple Sclerosis Society

Vibrant will participate in Bike MS NYC on Sunday, October 3 to increase awareness of Multiple Sclerosis and to raise money for the National Multiple Sclerosis Society. The race, hosted by the Southern NY Chapter of the National Multiple Sclerosis Society, will include nearly 6,000 cyclists across two Bike MS NYC locations.

1 Oct 2010

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for addiction and obesity, announced today that the Louisiana State University Health Sciences Center (LSUHSC-S) has received a $3.9 million dollar grant from the National Institute on Drug Abuse (NIDA). The grant will support the next stages of development for Embera's drug candidate EMB-001 to treat cocaine dependence, as well as advance EMB-001 into clinical testing.

1 Oct 2010

USFDA grants Sun Pharma tentative approval for generic Stalevo ANDA

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Orion's Stalevo® tablets.

1 Oct 2010

AcelRx completes ARX-02 End-of-Phase 2 meeting with FDA for cancer breakthrough pain management system

AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.

1 Oct 2010

CVS/pharmacy's fundraising campaign raises $4.1 million for ALS research

In just 21 days, CVS/pharmacy's ninth annual in-store fundraising campaign to support the fight against amyotrophic lateral sclerosis (ALS) brought in $4.1 million. The funds raised by the campaign will be donated to the Boston-based ALS Therapy Alliance (ATA) to support the funding of new clinical research aimed at developing new therapies for ALS patients and focused on the ultimate goal of finding a cure for ALS.

1 Oct 2010

Benicar better than Cozaar in reducing blood pressure: Study

New study results show that patients treated with Benicar® (olmesartan medoxomil) 40 mg once daily had significantly greater reductions in blood pressure and higher rates of goal attainment than patients receiving Cozaar® (losartan potassium) 100 mg once daily at week 8, according to findings of a new head-to-head study presented today at the late breaker session at the 23rd Scientific Meeting of the International Society of Hypertension (ISH) in Vancouver, Canada.

1 Oct 2010

Medical Condition News

Array BioPharma to present positive interim results of Phase 1 ARRY-380 trial at ASCO Symposium

Socioeconomic status impacts colorectal cancer incidence

CEUS ultrasound offers superior efficacy to CT scans

BMC researchers receive grants to study effectiveness of integrative medicine in underserved patients

Scientists find several common findings on diabetes management

Vitamin D deficiency in African-American women can increase risk of aggressive breast cancer: Study

Study shows low DRC level may increase risk for non-melanoma skin cancer

Celsion presents Phase I/II DIGNITY trial data at 2010 Breast Cancer Symposium

Sulindac drug derivative effective in preventing colon cancer: Research

Isotechnika announces CONFIRM1 clinical trial results at TCT 2010 Symposium

Osteoporosis common but underestimated in old men: Study

Shoulder pain costs American health system $7 billion

Argos' AGS-003 in combination with sunitinib demonstrates favorable PFS for renal cell carcinoma

Activating rearrangements in receptor genes are more common than previously thought

Vibrant joins Bike MS NYC to raise money for National Multiple Sclerosis Society

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

USFDA grants Sun Pharma tentative approval for generic Stalevo ANDA

AcelRx completes ARX-02 End-of-Phase 2 meeting with FDA for cancer breakthrough pain management system

CVS/pharmacy's fundraising campaign raises $4.1 million for ALS research

Benicar better than Cozaar in reducing blood pressure: Study

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News